VINC
Vincerx Pharma, Inc. Common Stock
VINC
VINC
Delisted
VINC was delisted on the 22nd of April, 2025.
28 hedge funds and large institutions have $7.9M invested in Vincerx Pharma, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+1
Holders Change %
+3.7%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $151 | – | – | – |
|
27
JPMorgan Chase & Co
New York
| $42 | +$42 | +3 | New |
|
|
FFA
28
Farther Finance Advisors
San Francisco,
California
| $7 | +$7 | +1 | New |
|
29
Citadel Advisors
Miami,
Florida
| – | -$144K | -8,912 | Closed |
|
30
Millennium Management
New York
| – | -$9.27K | -572 | Closed |
|
31
Focus Partners Wealth
Boston,
Massachusetts
| – | -$8K | -545 | Closed |
|
32
LPL Financial
San Diego,
California
| – | -$8.32K | -514 | Closed |
|
|
LP
33
LMR Partners
London,
United Kingdom
| – | -$8.1K | -500 | Closed |
|
34
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$4 | – | – |
|